https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001
Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
0
fool:-5077880577529416578
0
https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/?source=iedfolrf0000001
Apr 28, 2024 - There's no stopping this high-flying biotech.
0
fool:4208126404302670601
0
https://www.zacks.com/stock/news/2203352/eli-lilly-lly-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2203352
Dec 28, 2023 - The latest trading day saw Eli Lilly (LLY) settling at $580.85, representing a -0.11% change from its previous close.
zc:1328172185313880586
0
https://www.zacks.com/commentary/2204956/top-research-reports-for-amazon-com-berkshire-hathaway-eli-lilly?cid=CS-ZC-FT-research_daily-2204956
Jan 03, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Eli Lilly and Company (LLY).
zc:8350605169310386174
0
https://www.zacks.com/commentary/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy?cid=CS-ZC-FT-research_daily-2211986
Jan 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE).
zc:-2987126833864578149
0
https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146
Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
zc:-1303935316860058389
0
https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lilly-s-q4-earnings-beat?cid=CS-ZC-FT-etf_news_and_commentary-2222669
Feb 07, 2024 - Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.
zc:7686690040952392367
0
https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2256381
Apr 16, 2024 - In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.
zc:1250851567090083550
0
https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2259608
Apr 22, 2024 - Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
zc:1230330494755058603
0
https://www.zacks.com/stock/news/2195769/eli-lilly-lly-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2195769
Dec 08, 2023 - The latest trading day saw Eli Lilly (LLY) settling at $598.05, representing a +1.66% change from its previous close.
zc:5282848319989489655
0